Brief: Allovir Reports First Quarter 2022 Financial Results
05/05/2022 12:17
May 5 (Reuters) - Allovir Inc ALVR.O :
* ALLOVIR REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.69
Source text for Eikon: ID:nBwbdZrSva
Further company coverage: ALVR.O
Recent news on Kalaris Therapeutics
See all newsKalaris Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
Kalaris Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Kalaris Therapeutics posts smaller-than-expected Q1 net loss
Brief: Kalaris Therapeutics Inc Q1 Operating Income USD -11.833 Million